JPH0924085A5 - - Google Patents
Info
- Publication number
- JPH0924085A5 JPH0924085A5 JP1995175010A JP17501095A JPH0924085A5 JP H0924085 A5 JPH0924085 A5 JP H0924085A5 JP 1995175010 A JP1995175010 A JP 1995175010A JP 17501095 A JP17501095 A JP 17501095A JP H0924085 A5 JPH0924085 A5 JP H0924085A5
- Authority
- JP
- Japan
- Prior art keywords
- fasudil hydrochloride
- light
- aqueous solution
- wavelength
- container
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17501095A JP3879940B2 (ja) | 1995-07-11 | 1995-07-11 | 塩酸ファスジル注射剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17501095A JP3879940B2 (ja) | 1995-07-11 | 1995-07-11 | 塩酸ファスジル注射剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPH0924085A JPH0924085A (ja) | 1997-01-28 |
| JPH0924085A5 true JPH0924085A5 (2) | 2005-06-02 |
| JP3879940B2 JP3879940B2 (ja) | 2007-02-14 |
Family
ID=15988644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP17501095A Expired - Lifetime JP3879940B2 (ja) | 1995-07-11 | 1995-07-11 | 塩酸ファスジル注射剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3879940B2 (2) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5477996B2 (ja) * | 2003-09-30 | 2014-04-23 | ロート製薬株式会社 | 透明包装体入りトラニラスト含有医薬製剤 |
| JP5711957B2 (ja) * | 2003-09-30 | 2015-05-07 | ロート製薬株式会社 | 透明包装体入りトラニラスト含有医薬製剤 |
| CN1929847B (zh) | 2004-03-16 | 2011-01-19 | 旭化成制药株式会社 | 含有法舒地尔的制剂及改善其稳定性的方法 |
| US20070197648A1 (en) * | 2004-03-30 | 2007-08-23 | Rohto Pharmaceutical Co., Ltd. | Pharmaceutical product containing tranilast |
| JP5575100B2 (ja) * | 2004-12-28 | 2014-08-20 | ロート製薬株式会社 | プラノプロフェン含有組成物 |
| JP4958401B2 (ja) * | 2004-12-28 | 2012-06-20 | ロート製薬株式会社 | プラノプロフェン含有組成物 |
| JP4849816B2 (ja) * | 2005-02-08 | 2012-01-11 | ロート製薬株式会社 | プラノプロフェン含有医薬製剤 |
| CN102706997B (zh) * | 2012-06-28 | 2014-07-16 | 武汉武药科技有限公司 | 盐酸法舒地尔有关物质的检测方法 |
| PT3199161T (pt) * | 2014-09-25 | 2022-02-08 | Kowa Co | Preparação farmacêutica |
| CN106539755B (zh) * | 2016-12-08 | 2019-04-19 | 福州海王福药制药有限公司 | 一种盐酸法舒地尔注射液及其制备方法 |
| JP7822561B2 (ja) | 2020-09-04 | 2026-03-03 | コーニング インコーポレイテッド | 紫外光を遮断するコーティングされた医薬品包装 |
-
1995
- 1995-07-11 JP JP17501095A patent/JP3879940B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20040025919A (ko) | 외용 투여용 올로파타딘 제제 | |
| JP3879940B2 (ja) | 塩酸ファスジル注射剤 | |
| RU2127100C1 (ru) | Глазные капли "пиротоник" | |
| MD3310809T2 (ro) | Formularea anticorpului anti-CGRP | |
| DK160806B (da) | Stabil, vandig syreoploesning af cis-platin egnet til injektion og fremgangsmaade til fremstilling heraf | |
| Nham et al. | Severe thrombocytopenia in a patient with COVID-19 | |
| MXPA01011629A (es) | Composicion y metodo para la administracion parenteral de sal de d,l o l-lisina de ibupropeno. | |
| WO2025161380A1 (zh) | 一种含肾上腺素药液的预灌封装置、组合物及其制备方法 | |
| JP2003024415A (ja) | 注射剤容器 | |
| ES2250594T3 (es) | Composicion farmaceutica que comprende midazolam para administracion bucal. | |
| JP2021138649A (ja) | スガマデクス含有の液体製剤及びその製造方法 | |
| CN115969778A (zh) | 治疗精神疾病的舒必利注射液及其制法和用途 | |
| CA1166643A (en) | Salt of ¬(1-benzyl-1h-indazol-3-yl)oxy| acetic acid (or bendazac) with the lysine | |
| CA1262686A (en) | Composition to alleviate nausea and vomitting | |
| AU748034B2 (en) | Parenteral formulations comprising carbamazepine or its derivatives | |
| JPH03130226A (ja) | １つより多いエチレンイミン基を有する抗新生物性化合物用の安定な製薬学的配合及び方法 | |
| SE455045B (sv) | Stabil, koncentrerad losning av cisplatin | |
| CN1047076C (zh) | 稳定的注射剂及注射剂的稳定方法 | |
| RU2635759C1 (ru) | Фармацевтическая композиция для парентерального введения и способ ее получения | |
| IE55388B1 (en) | Stable pharmaceutical solutions of vinca alkaloids | |
| Waal-Manning et al. | Clinical studies with ketanserin in hypertension | |
| US5081153A (en) | Sterile parenteral composition | |
| Bradley | Naming of drugs. BMJ should use" paracetamol" instead of" acetaminophen" in its index | |
| Cook | Cerebral oedema after MDMA (" ecstasy") and unrestricted water intake. Values for plasma osmolality may have been wrong | |
| JPS5929617A (ja) | ビンカ・アルカロイド製剤 |